Investors may believe CareDx's strong revenue growth is not imminent, leading to a low P/S ratio. Expected future revenue decline could further decrease the P/S ratio, making a significant stock price rise unlikely.
Despite a strong price move, CareDx's P/S ratio still trails the industry. The low P/S is due to the forecast for sliding revenue. Without significant change, drastic rise in the stock is unlikely.
$ケアDx(CDNA.US)$Check out these highlights! ((. Reported revenue of $67.2 million, an increase of 7% over the second quarter of 2023, excluding approximately $7.8 million related to Medicare claims billing that were held over from the first quarter of 2023 and recognized in second quarter 2023 revenue. -- Grew Testing Services patient results to 38,400, an increase of 2% compared to the second quarter of 2023. -- Achieved revenue of $9.9 million for Digital Solut...
QUICK SCALP 17 $CDNA — STOCK & OPTION PLAY ALERT ON: $17.02 ON THE WATCH: $17.16 🥇 SIGNED OF MORE UPTREND: $17.28 NEED IT TO BREAK OVER: $17.37 key indicator for MORE uptrend $17.49 confirmation uptrend - $17.68 mini breakout - $17.84 Prepare for bigger breakout: $17.94.$ケアDx(CDNA.US)$
$ARK Innovation ETF(ARKK.US)$Renowned investor Cathie Wood, chief executive of Ark Investment Management, on May 26 bought into one of the world’s biggest and most prominent semiconductor makers, for the first time in at least several months. Ark funds snagged 245,286 shares of graphics-chip specialist$エヌビディア(NVDA.US)$valued at $43.8 million. In its earnings report for the April quarter, Nvidia beat sales and earnings per sh...
Hey Tupack@Pray4 tennis star, I am happy to see you back! I managed not losing money while you were out which for me is an extraordinary achievement! Would you mind commenting on$ケアDx(CDNA.US)$? It seems the price dropped after an investigation started. Do you see it recovering soon? Thanks a lot!
ケアDxに関するコメント
Nice!
On watch for tomorrow!
quarter of 2023, excluding approximately $7.8 million related to Medicare
claims billing that were held over from the first quarter of 2023 and
recognized in second quarter 2023 revenue.
-- Grew Testing Services patient results to 38,400, an increase of 2%
compared to the second quarter of 2023.
-- Achieved revenue of $9.9 million for Digital Solut...
ALERT ON: $17.02
ON THE WATCH: $17.16
🥇 SIGNED OF MORE UPTREND: $17.28
NEED IT TO BREAK OVER: $17.37
key indicator for MORE uptrend $17.49
confirmation uptrend - $17.68
mini breakout - $17.84
Prepare for bigger breakout: $17.94. $ケアDx(CDNA.US)$
Cathie Wood Watch: Buys Nvidia, Organ-Transplant-Services Provider
Ark funds snagged 245,286 shares of graphics-chip specialist $エヌビディア(NVDA.US)$ valued at $43.8 million.
In its earnings report for the April quarter, Nvidia beat sales and earnings per sh...
Sit-and-wait or run away?
まだコメントはありません